07/25/2024
5:06 AM | Agile Therapeutics (Filer)
| Form DEFM14A | |
07/22/2024
3:50 PM | Agile Therapeutics (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
| Form SC 13G | |
07/16/2024
3:15 PM | Agile Therapeutics (Filer)
| Form 8-K/A | |
07/16/2024
3:21 PM | Agile Therapeutics (Filer)
| Form DEFA14A | |
07/15/2024
3:35 PM | Agile Therapeutics (Filer)
| Form 8-K/A | |
07/12/2024
4:29 PM | Agile Therapeutics (Filer)
| Form PREM14A | |
07/09/2024
1:20 PM | Agile Therapeutics (Subject)
Beryl Capital Management LLC (Filed by)
| Form SC 13G | |
|
07/02/2024
2:44 PM | Agile Therapeutics (Subject)
Klein Roger M. (Filed by)
| Form SC 13G | |
06/27/2024
3:31 PM | Agile Therapeutics (Filer)
| Form RW | |
06/26/2024
7:15 AM | Agile Therapeutics (Filer)
| Form DEFA14A | |
06/26/2024
7:00 AM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
3:40 PM | Agile Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
06/03/2024
2:40 PM | Agile Therapeutics (Subject)
Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
05/21/2024
7:30 AM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2024
7:30 AM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
8:06 AM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
3:30 PM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2024
3:45 PM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/23/2024
3:55 PM | Agile Therapeutics (Filer)
| Form 424B5 | |
02/23/2024
3:57 PM | Agile Therapeutics (Filer)
| Form 424B5 | |
02/15/2024
3:45 PM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
7:02 PM | Agile Therapeutics (Subject)
Lind Global Fund II LP (Filed by)
| Form SC 13G/A | |
02/06/2024
9:14 AM | Agile Therapeutics (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
| Form SC 13G/A | |
02/05/2024
8:21 AM | Agile Therapeutics (Filer)
| Form S-1/A | |
12/20/2023
7:00 AM | Agile Therapeutics (Filer)
| Form S-1/A | |
12/11/2023
4:30 PM | Agile Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
12/06/2023
7:00 AM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2023
7:00 AM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
7:15 AM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
3:45 PM | Agile Therapeutics (Issuer)
Coiante Scott M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2023
3:30 PM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/28/2023
3:50 PM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/22/2023
7:30 AM | Agile Therapeutics (Filer)
| Form 8-K/A | |
08/09/2023
7:10 AM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free AGRX Stock Alerts